Signals of gastroesophageal reflux disease caused by incretin-based drugs: a disproportionality analysis using the Japanese adverse drug event report database

BACKGROUND: Incretin-based drugs are important in the treatment of type 2 diabetes. However, among the incretin-based drugs, glucagon-like peptide-1 receptor agonists (GLP-1-RAs) have been reported to cause gastroesophageal reflux disease (GERD)-like symptoms making it difficult to continue treatmen...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Pharm Health Care Sci
Egile Nagusiak: Noguchi, Yoshihiro, Katsuno, Hayato, Ueno, Anri, Otsubo, Manami, Yoshida, Aki, Kanematsu, Yuta, Sugita, Ikuto, Esaki, Hiroki, Tachi, Tomoya, Tsuchiya, Teruo, Teramachi, Hitomi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2018
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6004661/
https://ncbi.nlm.nih.gov/pubmed/29946474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40780-018-0109-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak